News
CPHI
0.6250
+9.65%
0.0550
Weekly Report: what happened at CPHI last week (0706-0710)?
Weekly Report · 14h ago
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga · 3d ago
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga · 07/06 21:05
Weekly Report: what happened at CPHI last week (0629-0703)?
Weekly Report · 07/06 10:34
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga · 06/30 21:05
Weekly Report: what happened at CPHI last week (0622-0626)?
Weekly Report · 06/29 10:28
Weekly Report: what happened at CPHI last week (0615-0619)?
Weekly Report · 06/22 10:39
Weekly Report: what happened at CPHI last week (0608-0612)?
Weekly Report · 06/15 10:39
Weekly Report: what happened at CPHI last week (0601-0605)?
Weekly Report · 06/08 10:34
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga · 06/02 21:09
Weekly Report: what happened at CPHI last week (0525-0529)?
Weekly Report · 06/01 10:40
Weekly Report: what happened at CPHI last week (0518-0522)?
Weekly Report · 05/25 10:44
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga · 05/18 17:05
Weekly Report: what happened at CPHI last week (0511-0515)?
Weekly Report · 05/18 10:44
China Pharma Holding Q1 EPS $(0.04) Up From $(0.24) YoY, Sales $983.536K Down From $1.136M YoY
Benzinga · 05/15 21:53
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga · 05/12 21:06
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga · 05/12 12:06
Weekly Report: what happened at CPHI last week (0504-0508)?
Weekly Report · 05/11 10:40
Weekly Report: what happened at CPHI last week (0427-0501)?
Weekly Report · 05/04 10:37
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 04/29 12:06
More
Webull provides a variety of real-time CPHI stock news. You can receive the latest news about China Pharma through multiple platforms. This information may help you make smarter investment decisions.
About CPHI
China Pharma Holdings Inc is a company principally engaged in the development, manufacture, and marketing of pharmaceutical products for human use. The Company is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for high-incidence and high-mortality diseases and medical conditions prevalent in the PRC. The Company's products include dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The Company's products and solutions are mainly applied in the treatment of various diseases and medical conditions. The Company mainly operates in the domestic market.